Clinical characterisation: Does SARS-CoV-2 injure the brain?
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-031
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
PendingResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Clinical characterisation of the neurological and cognitive effects of SARS-CoV-2 linked brain injury, by examining CNS effects of SARS-CoV-2 in an international collaborative effort to identify the frequency of such symptoms and how these can be detected, predicted, monitored and, potentially, treated. Project will include comparing cerebrospinal fluid/blood biomarker profiles for neuronal injury and neuroinflammation between COVID-19 positive patients with and without neurological symptoms.